SCHEMBL24950558

SCHEMBL24950558

CCCOC(=O)C(N)CCCl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 2/20 0.37
HCAR2 Q8TDS4 1/20 0.34
ALDH1A1 P00352 4/20 0.33
SLC1A2 P43004 3/20 0.33
SLC1A1 P43005 3/20 0.33
SLC1A3 P43003 2/20 0.33
GRIK1 P39086 2/20 0.33
GRIK2 Q13002 2/20 0.33
LMNA P02545 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26269822 1.00 NOD1 (0.37) NOD1HCAR2ALDH1A1SLC1A2SLC1A1
SCHEMBL24950559 0.89 ALDH1A1 (0.45) NOD1HCAR2ALDH1A1SLC1A2SLC1A1
SCHEMBL24950470 0.89 ALDH1A1 (0.45) NOD1HCAR2ALDH1A1SLC1A2SLC1A1
SCHEMBL1096747 0.85 SLC1A2 (0.41) NOD1HCAR2ALDH1A1SLC1A2SLC1A1
SCHEMBL453102 0.85 SLC1A2 (0.41) NOD1HCAR2ALDH1A1SLC1A2SLC1A1
SCHEMBL23660120 0.83 ALOX15 (0.41) NOD1ALDH1A1LMNASMN1; SMN2
SCHEMBL14483975 0.83 ALOX15 (0.41) NOD1ALDH1A1LMNASMN1; SMN2
SCHEMBL60117 0.82 NOD1 (0.38) NOD1HCAR2ALDH1A1SLC1A2SLC1A1
Hydrochloric Acid SCHEMBL29023852 0.82 ALOX15 (0.39) NOD1ALDH1A1LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL28928940 0.82 ALOX15 (0.39) NOD1ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257405-A1 METHOD FOR PREPARING GLUFOSINATE OR ANALOGUES THEREOF LIER CHEMICAL CO., LTD. (CN) 2023-08-17 US disclosed
US-20230257405-A1 METHOD FOR PREPARING GLUFOSINATE OR ANALOGUES THEREOF LIER CHEMICAL CO., LTD. (CN) 2023-08-17 US disclosed
EP-4219512-A1 METHOD FOR PREPARING GLUFOSINATE OR ANALOG THEREOF Lier Chemical Co., Ltd. (CN) 2023-08-02 EP disclosed
WO-2023001132-A1 METHOD FOR PREPARING GLUFOSINATE OR ANALOG THEREOF 利尔化学股份有限公司 2023-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257405-A1 METHOD FOR PREPARING GLUFOSINATE OR ANALOGUES THEREOF FPGS, TYMP, GLUL NOD1 3768/4885HCAR2 4238/4885ALDH1A1 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.